AOD 9604 5mg

AOD 9604 Dragon Pharma

AOD9604, also known as Fragment 176-191 or Hexarelin, is a synthetic peptide that has been the subject of significant scientific interest and research in the fields of regenerative medicine, endocrinology, and anti-obesity therapies. This compound is a piece of the larger human growth hormone-releasing factor (hGRF), specifically a 29-amino acid fragment (176-191). It was developed by Professor Frank J. S. Nargi and his team at the Monash University School of Biomedical Science in Australia.

The primary function of AOD9604 is to mimic the natural growth hormone-releasing peptides (GHRPs) in the human body, which are involved in the regulation of growth hormone (GH) secretion. GH is a peptide hormone produced by the pituitary gland that plays a crucial role in growth, cell regeneration, and metabolism. AOD9604 is particularly unique because it shares a similar molecular structure to human growth hormone-releasing hormone (GHRH) and acts on the same receptors in the pituitary gland, but with a significantly truncated length. This allows it to be more resistant to metabolic breakdown and exhibit a longer half-life than natural GHRPs.